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Acquired resistance to a variety of obligate or facultative intracellular pathogens
is dependent on cell-mediated immunity (1-3). Mononuclear phagocytes play a
major role in this defense mechanism (2, 3) . Lymphocytes from immunized
subjects produce in response to antigenic stimulation substances which induce
morphologic, metabolic, and functional changes in human monocytes (4, 5) .
However, little is known about the effects of these lymphocyte mediators on the
interaction of human monocytes with specific intracellular parasites.
The obligate intracellular organism, Toxoplasma gondii, is well suited for the
experimental evaluation of cellular immunity. Studies in animals have indicated
that development of cellular immunity is the major factor in slowing the
progression of toxoplasma infection in vivo (6, 7) . Intracellular multiplication of
this organism in vitro can be reproducibly quantitated by phase-contrast
microscopy in normal (8) and immune mouse cells (6).
The present studies describe an in vitro model for the quantitation of the
multiplication of T. gondii in monocytes from normal and immune human
subjects. The findings show that the capacity to inhibit growth of toxoplasmas is
induced in monocytes by a product released after exposure of T lymphocytes
from immune subjects to toxoplasma antigen.
Materials and Methods
Subjects and Serum Preparation. Serum and mononuclear cells were obtained from healthy
laboratory personnel. All sera were passed through a 0.45 jum Millipore filter (Millipore Corp.,
Bedford, Mass.), heat inactivated at 56°C for30 min, and stored at -20°C. Sabin-Feldman dye tests
and toxoplasma complement (C) fixation tests were performed by Dr. Anne Kimball, Cornell
University Medical College, NewYork (9).
Collection, Separation, andCulture of Mononuclear Cells.
￿
Human peripheral mononuclear cells
were separated from heparinized venous blood by centrifugation over a Ficoll-Hypaque gradient as
described by Gordon et al. (10) . The mononuclear band was resuspended in phosphate-buffered
saline containing 0.3 mM EDTA and centrifuged at 500 g for 10 min. The cells were resuspended in
RPMI-1640 with penicillin and streptomycin (RPMI) (Associated Biomedic Systems, Inc., Buffalo,
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N. Y.) and 5% heat-inactivated human serum (HIHS) .' 0.5 ml of the mononuclear cell-rich
suspension containing 10' cells/ml was carefully placed on 22-mm' glasscover slips in plastic dishes
(35 x 10 mm, Falcon Plastics, Div. of BioQuest, Oxnard, Calif.) . After 90 minofincubation (37°C) in
5%CO./95% air about 10% of the cells were adherent to glass . The nonadherent cells were removedby
washing four times withRPMI and designated as lymphocytes . Giemsa-stained smears of these cells
revealed 95%lymphocytes, 3-4% monocytes, and 1-2% polymorphonuclear leukocytes . Adherent cells
were 95% monocytes and 5% lymphocytes by morphologic criteria (11) . Monocytes were maintained
in culture for 1-3 days before infection with T. gondii .
Separation of Thymus-Derived (T) Lymphocytes and Bone Marrow-Derived (B) Lymphocytes .
Lymphocyteswere rosetted with neuraminidase-treated sheep redblood cells(SRBC) as described by
Weiner et al . (12) .Therosetted and nonrosettedlymphocyteswere centrifuged over aFicoll-Hypaque
gradient (200 g for 10 min) . Rosetted lymphocytes (T cells) were pelleted, owing to their greater
density, whereas the nonrosetted lymphocytes appeared as a sharp band in the Ficoll-Hypaque
mixture . The SRBC in the rosetted lymphocyte preparation were lysed with ammonium chloride
(0.83% in distilled H2O) (J . T. Baker Chemical Co ., Phillipsburg, N. J .) . Samples from the two
populations of lymphocytes (T-cell rich or B-cell rich) were again rosetted and also treated with
antihuman IgG fluorescein-labeled antibody (13) to determine the efficiency of the separation
procedure .
Preparation of Lymphocyte Products . Mononuclear cells obtained from the Ficoll-Hypaque
gradient were suspended in RPMI-5% HIHS in plastic tubes (17 x 10 mm ; Falcon Plastics, Div. Of
BioQuest) . Lymphocyte products were prepared by incubating (5% CO Z/95% air, 37°C) 2.5 x 10 8 of
these cells for periods varying from 15 min to 96 h with either : (a) 20 Wg/ml of toxoplasma antigen or
(b) 50 jg/ml of ConAor (c) 10,ug/ml of purified protein derivative (PPD) . Control tubes lacked either
antigen or lymphocytes . After incubation, tubes were cooled to 4°C and centrifuged at 1,400 gfor 20
min. The supernates were designated as lymphocyte products and stored at 4°C .
Incubation of Lymphocytes or Lymphocyte Products with Monocytes .
￿
Monocytes were cultured
for 1.5-96 hbefore the addition of 2.5 x 10 8 intact lymphocytes (starting mixture, T-cell rich or B-cell
rich) and toxoplasma antigen or mitogen . The cells were then incubated (5% CO./95% air, 37°C) in
2.5 mlRPMI-5% HIHS for 2-72 h before infection with T . gondii . The concentrations of antigen or
mitogen were identical to those used in the preparation of lymphocyte products . Control monocyte
cultures excluded either lymphocytes or antigen and mitogen . Lymphocyte products were similarly
incubated with monocytes for 2-48 h before infection with T . gondii .
Lymphocyte Transformation . Lymphocyte transformation studies utilized mononuclear cells
from the Ficoll-Hypaque mixture and employed the micro method and concentrations of phytohe-
magglutinin (PHA), pokeweed mitogen (PWM), and concanavalin A (Con A) described by Weksler
and Hutteroth (13) . 2 x 105 cells were also incubatedwith either toxoplasma antigen (10 jug) or 0.5 jug
of preservative-free PPD (Parke, Davis & Co ., Detroit, Mich .) in 0.2 ml of RPMI with 20%
heat-inactivated heterologous human AB serum. All studies were performed in triplicate and all
cultures were incubated (5% CO ./95% air, 37°C) for 72 hexcept those with PPD (120 h) . Control cells
were incubated with culture media alone .
HeLa Cells .
￿
HeLa cells obtained from Dr.L . Senterfit (Cornell University Medical College, New
York) were cultured in plastic flasks in minimum essential medium (MEM) (Microbiological Asso-
ciates, Inc., Bethesda, Md .) with 10% heat-inactivated fetal calf serum (HIFCS) (Grand Island Bio-
logical Co ., Grand Island, N . Y .) and monolayers were prepared as describedby Jones et al . (8) . The
procedures for incubation of HeLa cells with lymphocytes or lymphocyte products and the infection
andquantitation of toxoplasma intracellular multiplication were the same as described formonocytes .
Maintenanceand Collection of T . gondii andPreparation of Toxoplasma Antigen . TheRH strain
ofT . gondii, originally isolated by Sabin (14),wasobtained from Dr.Thomas Jones (Cornell University
Medical College, New York) . The strain was maintained by intraperitoneal passage in CFW male
mice, and living toxoplasmas, as well as solubletoxoplasma antigen(s), were prepared from parasite-
rich mouse peritoneal exudates (15) . The toxoplasma antigen was quantitated by the protein con-
tent as determined by the Lowry method and stored at -20°C (16) .
Infection of Monocyte Monolayers with T . gondii and Quantitation of Parasite Multiplica-
'Abbreviations used in this paper : Con A, concanavalin A; GT, generation time ; HIFCS,
heat-inactivated fetal calf serum; HIHS, heat-inactivated human serum ; MIF, migration inhibition
factor ; PHA, phytohemagglutinin; PPD, purified protein derivative ; PWM, pokeweed mitogen .JAMES S. BORGES AND WARREN D. JOHNSON, Jr.
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The glass adherent monocytes were washed four times with RPMI before exposure to 1 x 108
toxoplasmas in 1 ml of MEM-20%HIFCS for30 min at 37°C in 5% C0,/95% air. Thecellswere then
washed twicewith RPMI to remove extracellular toxoplasmas and incubated (5% CO05%air, 37°C)
in 2 ml of RPMI 5% HIHS. After incubation for 1-24 h, infected monocytes were fixed in 2.5%
glutaraldehyde in 0.1 M Na cacodylate (pH 7.4) at 4°C. Thecoverslipswere removed from the dishes,
inverted on glass slides, rimmed with paraffin, coded, and examined by phase-contrast microscopy
with a 63x or 100x objective. The mean number of toxoplasmas per vacuole was determined by
counting the parasitesin 50 vacuoles for each monocyte preparation. Toxoplasma growth curves were
constructed and the mean toxoplasma generation time (GT) was calculated by standard methods
(17).
Results
Profile of Study Subjects.
￿
A profile of the study subjects and the results of
their lymphocyte transformation studies with toxoplasma antigen and PPD are
shown in Table 1. Subjects A, B, and C had positive Sabin-Feldman dye tests
documented for 60, 24, and 8 mo, respectively. Subjects D and E repeatedly had
negative tests (<1:2).
Lymphocytes from all subjects responded to PHA, Con A, and PWM with
increased (30- to 250-fold) incorporation of tritiated thymidine as compared with
controls. Subjects A, B, and C (dye test positive) had increased incorporation of
thymidine (about 10-fold) with toxoplasma antigen whereas the response of
subjects D and E was insignificant. The mitogenic response to toxoplasma
antigen of lymphocytes from the dye test-positive, and presumably immune
subjects, was comparable in magnitude to that of cells from a tuberculin-sensi-
tive individual after exposure to PPD.
Multiplication of T. gondii in Human Monocytes.
￿
30 min after infection of
monocytes in vitro, parasites were present within cytoplasmicvacuoles of 15-20%
TABLE I
Profile of Study Subjects and Results of Lymphocyte Transformation Studies with
Toxoplasma Antigen and PPD
* Results are expressed as the mean with one standard deviation. Statistical analysis utilized the
unpaired Student's t test. The combined results of lymphocytes from subjects A, B, and C and
toxoplasma antigen aresignificantly different from both theircontrol cultures and lymphocytes from
subjects D andEwith toxoplasma antigen (P < 0.0005). Theresponse of lymphocytes from subject B
to PPD is significantly different from both his control cultures and lymphocytes from subject D and
PPD (P < 0.01) .
tControl lymphocytes were incubated with culture media alone.
Subject Age/sex Sabin-Feldman
dyetest
Tuberculin
skin test
Lymphocyte
(cpm thymidine
Control$
transformation*
incorporated
Toxoplasma
antigen
x 10-3)
PPD
A 36M 1:256 0.3 t 0.1 4.4 t 2.3
B 28M 1:16 Positive 0.3 t0.1 2.2 f 1.5 2.0 t 1.1
C 36F 1:256 0.3 t 0.1 3.1 t 1.2
D 30M Negative Negative 0.1 t0.1 0.6 f0.2 0.2 f 0.1
E 40M Negative 0.4 t0.1 0.5 t0.2486
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of the cells. The age of the monocyte culture did not influence the percent of cells
parasitized. However, a greater percentage of cells was parasitized if either the
number of infecting toxoplasmas or the duration of their exposure to the
monocytes were increased. Multiple vacuoles containing toxoplasmas were
uncommonly seen within a single cell.
The growth curve of T. gondii in monocytes from subjectD (dye test negative)
is shown in Fig. 1. The parasites entered an exponentialphaseof growth aftera 10
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FIG. 1 . Growth curve of T. gondii in monocytes from Sabin-Feldman dye-test-negative
subject. The bar represents one standard deviation.
h lag period and the average number of toxoplasmas per vacuole increased from
1.0 to 3.8 by 20 h after infection. Further parasite multiplication during an
additional 4-6 h of incubation destroyed the monocytes. The mean toxoplasma
GT calculated from this curve was 5 h and 10 min. This is in agreement with the
mean GT of this strain of T. gondii in other mammalian cells (8).
The multiplication of toxoplasmas in human monocytes wasnot influenced by
the age of the monocyte culture (1.5-96 h) or the presence of toxoplasma immune
HIHS either during the initial monocyte cultivation or during incubation of
monocytes after infection. There was no difference in parasite multiplication in
monocytes infected with toxoplasmas in media containing 20% dye test-positive
(titer of 1:256) HIHS compared to dye test-negative HIHS or HIFCS. Observa-
tions were not made on possible influences of these various sera on the rate of
uptake of toxoplasmas or on parasite survival during the early postphagocytic
period.
Effect of Immune Lymphocytes and Toxoplasma Antigen on the Multiplica-
tion of T. gondii in Monocytes. Monocytes from the test subjects were cultured
in vitro with various combinations of autologous lymphocytes and toxoplasma
antigen for 24 h. After washing to remove lymphocytes and antigen, the
monocytes were infected with toxoplasmas. As shown in Table 11, multiplication
of toxoplasmas was significantly inhibited in those monocytes which were
previously exposed to both toxoplasma antigen and lymphocytes from dye
test-positive subjects. Monocytes preincubated with only lymphocytes or anti-
gen, but not both, did not acquire the capacity to suppress parasite multiplica-JAMES S. BORGES AND WARREN D. JOHNSON, Jr.
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TABLE II
Multiplication of T. gondii in Monocytes Cultured with Combinations of Autologous
Lymphocytes and Toxoplasma Antigen
Averageno . of toxoplasmas per vacuole
Lymphocyte
￿
20 hafter infection in monocytes
*Monocytes were preincubated for 1 daybefore infection with either toxoplasma antigen, autologous
lymphocytes, or both lymphocytes and toxoplasma antigen.
fOne standard deviation is indicated when the mean is derived from four or more separate
experiments.
tion . Lymphocytes from nonimmune subjects did not induce in monocytes the
capacity to inhibit growth of toxoplasmas, even when toxoplasma antigen was
present. The source of the monocytes (i.e., immune or nonimmune donors) was
irrelevant; lymphocytes from immune subjects plus toxoplasma antigen induced
in monocytes from nonimmune as well as immune persons the capacity to inhibit
toxoplasma multiplication. Monocytes cultured with heterologous lymphocytes
were indistinguishable from those cultured with autologous lymphocytes by
morphologic criteria, i.e., spreading on glass and ruffled membrane activity .
The mean toxoplasma GT calculated from the parasite growth curves shown in
Fig. 2 was prolonged from 5 h and 10 min to 8 h by exposure of immune
lymphocytes and monocytes to toxoplasma antigen for 1 day before infection of
the monocytes. There was no prolongation of the lag phase preceding toxoplasma
multiplication but rather a slowing of the parasite division time after the lag
period.
Lymphocyte Requirements and Kinetics of their Effect on Monocytes .
￿
The
number of immune lymphocytes required with toxoplasma antigen to stimulate
monocyte inhibition of toxoplasma multiplication was also studied.
Mononuclear cells (5 x 106) were cultured on glass for 1.5 h as described and then washed five
times with RPMI to remove nonadherent lymphocytes. The lymphocytes were pooled, counted, and
resuspended in fresh media with toxoplasma antigen. Different numbers of lymphocytes were then
returned to the washed monocytes and incubated for 24 h before toxoplasma infection .
Maximal inhibition of toxoplasma multiplication resulted when monocytes
were preincubated with 2-4 x 108 lymphocytes (approximately a 10:1 lym-
phocyte:monocyte ratio), whereas no suppression of parasite multiplication was
seen with 1 x 106 lymphocytes. Increasing the number of lymphocytes to 1 x 107
did not enhance the inhibition of toxoplasma growth.
Observations were also made on the time required for immune lymphocytes
Subject Sabin-Feldman
dye test
transformation
with
toxoplasma
antigen Toxoplasma
antigen
preincubated with:
Lymphocytes
Lymphocytes
andtoxoplasma
antigen
A Positive Yes 4.0 f0.2$ 3.9 f0.3 2.4 t 0.2
B Positive Yes 4.0 3.7 t0.3 2.4 t0.2
C Positive Yes 3.8 3.8 2.3
D Negative No 4.1 3.7 t0.3 3.8 t 0.2
E Negative No 3.8 3.7 3.7488
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FIG. 2.
￿
Growth curve ofT . gondii in monocytes from a dye-test-positive subject which have
been preincubated with autologous lymphocytes in the presence or absence of toxoplasma
antigen . The bars represent one standard deviation .
and toxoplasma antigen to induce in monocytes the capacity to inhibit
toxoplasma multiplication . Monocyte cultures washed to remove the lympho-
cytes and antigen at times ranging from 2 h to 72 h all exhibited the same
capacity to inhibit parasite multiplication (Table III) . The addition of both
toxoplasma antigen and lymphocytes from immune subjects after monocytes
were infected resulted in a similar degree of inhibition oftoxoplasma multiplica-
tion . Monocytes preincubated with immune lymphocytes and toxoplasma
antigen for 24 h and then washed and maintained in fresh culture media for 48 h
completely lost their capacity to inhibit multiplication of toxoplasmas .
Demonstration that T Lymphocytes are Responsible for the Induction in
Monocytes of the Capacity to Inhibit Toxoplasmas . In order to determine the
subpopulation ofimmune lymphocytes primarily responsible for the induction of
inhibition of toxoplasma multiplication, rosettedT lymphocytes were separated
from nonrosettedB lymphocytes on Ficoll-Hypaque . In four experiments, there
was a mean of 68% rosetting T cells in the starting lymphocyte mixture from
subject A (Table IV) . After separation, the population enriched in T cells
contained an average of83% rosetting cells andthe population enriched inB cells
had an average of 15% rosetting lymphocytes. The percentage of immuno-
globulin-bearing lymphocytes in the T- and B-cell-rich populations was 10% and
95%, respectively .
2.5 x 1011 immune lymphocytes from either the starting lymphocyte mixture or
the separated T- or B-cell-rich populations were preincubated for 24 h with
monocytes and toxoplasma antigen. As shown in Table IV, there was inhibition
of toxoplasma multiplication in the monocytes preincubated with either the
starting lymphocyte mixture or with the T-cell-rich population . In contrast,
monocytes preincubated with the B-cell-rich population acquired no demonstra-
ble capacity to inhibit toxoplasma multiplication . The number of lymphocytes
used here was just above the minimum required for full induction of monocytes,JAMES S . BORGES AND WARREN D. JOHNSON, Jr.
TABLE III
Exposure Time of Monocytes to Toxoplasma Antigen and Immune
Lymphocytes
Incubation period of immune
lymphocytes andtoxoplasma
antigen with monocytes before
toxoplasma infection
* One standard deviation.
TABLE IV
Multiplication of T. gondii in Monocytes Cultured with Toxoplasma Antigen and
Lymphocyte Populations Enriched in T or B Cells
Average no. of toxoplasmas
per vacuole in monocytes 20
h after infection
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thus a B-cell-rich population containing 15% T cells would be expected to be
inactive.
Multiplication of T. gondii in Monocytes and HeLa cells Exposed to
Lymphocyte Products . Supernates (lymphocyte products) were collected after
incubation of toxoplasma antigen with lymphocytes from three dye test-positive
subjects and a dye test-negative subject. These supernates were incubated with
monocyte cultures for 24 h before toxoplasma challenge. As shown in Table V,
supernates of lymphocytes from the dye test-positive subjects and antigen
induced significant monocyte inhibition of toxoplasma multiplication, whereas
no inhibition resulted from supernates of lymphocytes alone or supernates of
lymphocytes from the dye test-negative subject and antigen. There was no
difference in toxoplasma multiplication in monocytes exposed to these various
lymphocyte products for short periods (2 h) compared to longer periods (48 h) .
Supernates were also prepared from T- and B-cell-rich lymphocyte popula-
tions from a dye test-positive subject and toxoplasma antigen. T-cell-rich
supernates induced monocytes to inhibittoxoplasma multiplication as effectively
Lymphocyte population
Percentage of
Rosette-forming
cells
lymphocytes
Immunoglobulin-
bearing cells
Average no. oftoxo-
plasmas per vacuole
in monocytes 20
hafter infection
Starting mixture 68(64-74) 34 2.4
T-cell rich 83(72-89) 10 2.3
B-cell rich 15 (8-18) 95 4.0
None - - 4.2
h
2 2.3 t 0.1*
24 2.4 t 0.2
48 2.3 f 0.1
72 2.5 t 0.2
72 (without antigen) 4.0t 0.3490
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as did the starting lymphocyte mixture supernates (Table VI) . No inhibition was
induced by the B-cell-rich supernates .
Supernates prepared by incubation ofimmune lymphocytes and toxoplasma at
37°C for as little as 15 min were active in inducing monocytes to inhibit
toxoplasma multiplication . Supernates collected after 2, 24, or 72 h of incubation
of lymphocytes and toxoplasma antigen could be diluted 1:4 without any loss of
activity . Supernates prepared at 4°C were completely inactive . Active super-
nates could be stored at 4°C for 1 mo without loss of activity . Activity was lost
when supernates were heated at 56°C for 30 min .
Supernates which induced human monocytes to inhibit toxoplasma multi-
plication did not influence parasite growth in HeLa cells . In two experiments,
HeLa cells preincubated for 1 day with either active supernates or intact immune
lymphocytes and toxoplasma antigen had an average of8.2 toxoplasmas/vacuole
24 h after infection . HeLa cells preincubated with only lymphocytes or culture
media had 8.7 toxoplasmas/vacuole .
Toxoplasma Multiplication in Monocytes Exposed to Lymphocyte Products
Composition of lymphocyte products
(supernates) preincubated with
monocytes before infection
Lymphocytes
(dye test of donor)
Positive
￿
Present
Positive
￿
Absent
Negative
￿
Present
Negative
￿
Absent
No lymphocytes
￿
Present
* One standard deviation .
f Combined results of experiments with lymphocytes from three dye test-positive subjects .
TABLE VI
Toxoplasma Multiplication in Monocytes Exposed to T- and B-Cell
Lymphocyte Products
TABLE V
Toxoplasma antigen
Average no . of toxoplasmas
per vacuole in monocytes 20
h after infection
2.4 t 0.1*, f
4.0t 0.1
3.9f 0.1
3.9 f 0.1
4.1 t 0.3
*Lymphocytes were cultured with toxoplasma antigen for 1 day and the resulting
lymphocyte products were then incubated with monocytes for 24 h before toxoplasma
challenge .
$One standard deviation .
Lymphocyte population*
Average no . of toxoplasmas
per vacuole in monocytes 20
h after infection
Starting mixture 2.4f 0.1$
T-cell rich 2.4 f 0.1
B-cell rich 3.9t 0.1JAMES S. BORGES AND WARREN D . JOHNSON, Jr.
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Specificity of Lymphocyte-Antigen Effect on Monocytes .
￿
Monocytes from
subjects B and D were incubated for 24 h with 3-4 x 108 autologous lymphocytes
and either toxoplasma antigen (50 gg) or PPD (100 lAg) before infection with T.
gondii . Subject B had evidence ofimmunity to both Mycobacterium tuberculosis
and T. gondii, as evidenced by a positive PPD and a positive Sabin-Feldman dye
test, as well as a similar degree of lymphocyte blastogenesis in response toPPD or
to toxoplasma antigen . Subject D had no evidence of immunity to either microbe
(Table I) . Monocytes cultured with lymphocytes from subject B and toxoplasma
antigen inhibited toxoplasma multiplication, whereas monocytes preincubated
with this subject's lymphocytes and PPD did not (Table VII) . Toxoplasma
multiplication in monocytes from subject D was uninhibited under all test
conditions . No inhibition of toxoplasma multiplication occurred in monocytes
incubated with Con A-stimulated lymphocytes, their supernates or supernates of
lymphocytes from the tuberculin-positive subject, and PPD .
Discussion
The obligate intracellular parasite, T. gondii, is a common cause of human
infection . Serologic surveys utilizing the Sabin-Feldman dye test indicate that
about 40% of the United States population has had toxoplasmosis by age 50 (18) .
Although toxoplasmosis is commonly asymptomatic, it can produce a fulminant
illness in the immunosuppressed patient or the fetus (19, 20) . While host factors
which control this infection are not completely understood, cell-mediated
immunity appears to be a major determinant in halting the progression of this
infection . There is abundant evidence that cell-mediated immunity plays a
major role in the host defense against T . gondii in mice (6) and hamsters (7) . In
humans delayed-type skin hypersensitivity (21) and lymphocyte transformation
to toxoplasma antigens have been demonstrated (22), and evidence also indicates
that macrophages from immune subjectscan inhibit toxoplasma growth (23, 24) .
In the present report an in vitro system has been utilized to quantitate the
intracellular multiplication of T. gondii in human monocytes, and to character-
ize aspects of the cellular immune response of man . T . gondii is well suited for
TABLE VII
Toxoplasma Multiplication in Monocytes Cultured with Autologous Lymphocytes and
PPD or Toxoplasma Antigen
* One standard deviation .
Monocyte culture conditions before infection
Lymphocyte source
with T. gondii
Antigen
Averageno . of toxoplasmas
pervacuole in monocytes 20
hafter infection
SubjectB (immune to toxoplasmosis and Toxoplasma 2.4 t 0.2*
tuberculosis) PPD 3.8
SubjectD (not immune to toxoplasmosis Toxoplasma 3.8 t 0.2
or tuberculosis) PPD 3.8492
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quantitative studies ; it is sufficiently large to count directly, and determine
viability under the phase-contrast microscope (8), and it is then possible to
calculate the generation time of the intracellular organisms . Such a direct
method circumvents many of the problems of studies employing bacterial models
in which colony counts are employed ; in these models extracellular multiplica-
tion of organisms often cannot be excluded, and intracellular localization cannot
be determined with certainty in stained preparations .
Toxoplasma growth curves in cultures of human monocytes from immune and
nonimmune subjects were identical when these cells were not exposed in vitro to
toxoplasma antigen and immune lymphocytes . While this is in agreement with
recent observations utilizing human macrophages (23), it conflicts with animal
studies in which some peritoneal macrophages from toxoplasma-infected mice
inhibit parasite multiplication without prior in vitro exposure to toxoplasma
antigen (25) . Anderson and Remington postulated that the contrasting results
with human and mouse macrophages might relate to the prolonged in vitro
culture period (5-8 days) of thehuman cells (23) . This seems unlikely since in our
studies the age of the monocyte cultures (90 min to 4 days) did not influence
toxoplasma multiplication . It is more plausible that this variation in macrophage
response is related to the generally longer interval between infection-immunity
and study in humans . Jones et al . have now shown that mouse peritoneal
macrophages inhibit toxoplasmas without additional antigen exposure in vitro
during the period 16-75 days after infection, but after that time in vitro contact
with antigen and immune lymphocytes is required (15) . The source of cells
studied in the human (blood) and mouse (peritoneal cavity) is also different and
could contribute to the variation in macrophage response . Mouse peritoneal
macrophages might be exposed in vivo to different numbers or types of
lymphocytes, to localized antigen or intact parasites, or to different concentra-
tionsofserum factors . Furthermore, the peritoneal cavity might provide a greater
opportunity for contact between the macrophage and these factors .
In the present study, toxoplasma multiplication was inhibited only in those
monocytes preincubated with toxoplasma antigen and lymphocytes from a
toxoplasma-immune subject or to soluble factors produced by these two agencies .
Parasite growth curves indicated that this inhibition did not result from a
prolongation of the "lag phase" preceding multiplication but from a slowing in
the toxoplasma division time after the lag period .
The mechanism whereby the monocyte inhibits toxoplasma multiplication is
unknown . Jones and Hirsch have demonstrated in electron microscopy studies
that there is a lack of fusion ofphagosomes containing viable toxoplasma and the
lysosomal granules of normal mouse peritoneal macrophages (26) . They have
recently reported that toxoplasma-immune mouse macrophages which were
capable of inhibiting parasite multiplication similarly demonstrate a failure of
fusion between phagosomes and lysosomes (15) .
Toxoplasma multiplication in human monocytes was not influenced by
exposure of the parasites to heat-inactivated dye test-positive human serum
before infection of the monocytes or by the addition of antibody to the medium
after the toxoplasma were intracellular . Although these experiments do not
exclude a role for cytophilic antibody, they indicate that conventional humoralJAMES S. BORGES ANDWARREN D . JOHNSON, Jr .
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antibody does not play a role in the intracellular inhibition of toxoplasma
multiplication (27) .
Evaluation of the role of the various types of lymphocytes in human cellular
immune reactions has been hampered by the unavailability, until recently, of
suitable methods for separating T andB lymphocytes . The critical role of the T
cell in experimental animal models is evident in studies in which the passive
transfer of immunity to Listeria monocytogenes was abolished by pretreatment
of the transferred lymphocytes with antitheta antiserum and C (28), and the
demonstration thatT cells are essential for resistance to mouse pox and murine
listeriosis (29-31) . In our studies we utilized the distinctive property ofhumanT
cells to form rosettes with SRBC (32) to obtain a T-cell-rich lymphocyte
population . TheT cell was then shown to be primarilyresponsible forstimulating
monocytes to inhibit toxoplasma multiplication .
In the present study, supernates obtained from antigen-stimulated lympho-
cytes from immune subjects induced in monocytes the capacity to inhibit
toxoplasma multiplication as effectively as did intact lymphocytes and antigen.
In contrast, Fowles et al . reported intact lymphocytes and antigen were more
effective in enhancing macrophage bacteriostasis than soluble lymphocyte
products (33) . These differences may reflect variations in the host species
(human or guinea pig) or in the infectious agent (toxoplasma or listeria) studied .
In the toxoplasma system the active material was released into the supernate
quite rapidly (within 15 min), indicating that lymphocyte transformation and
"standard" migration inhibition factor (MIF) release arenotprerequisitesfor the
inhibition of toxoplasma multiplication, since these processes require a much
longer time . In- previous reports a minimum of 18-24 h has been required to
generate lymphocyte products which alter macrophage metabolism or function
(33-35) . The very brief contact period between lymphocyte and antigen in our
system suggests the passive release of a preformed lymphokine . The absence of
any monocyte-stimulating activity in supernates prepared at 4°C indicates that
cellular metabolism is required either to produce or release the substance . The
prompt release seen in our system is not too surprising, since in other studies on
lymphocyte activation, membrane lipid turnover or synthesis, active pinocytosis,
acetylation of histones, and phosphorylation of nucleoproteins were discernable
within 15 min of the addition of a transforming agent (36) .
The instruction of monocytes to inhibit toxoplasma multiplication by both
intact lymphocytes and antigen, or their supernate, was also rapid, and
completed in 90-120 min. In other in vitro systems, 1-10days of contact between
mononuclear phagocytes and lymphocyte mediators was required to induce
metabolic or functional changes in the cells (37-42) . This variability probably
reflects the diversity of the in vitro systems employed in these studies . The
addition of lymphocytes and antigen immediately after monocytes were infected
with toxoplasmas also resulted in inhibition of parasite multiplication . When
monocytes incubated with lymphocytes from immune subjects and antigen for 1
day were washed, and then cultured an additional 2 days in fresh media alone,
they lost their ability to inhibittoxoplasma multiplication . A similarreversibility
in this type of induced macrophage function has been reported by Nathan et al .
(38) .494
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Supernates of toxoplasma-immune lymphocytes and specific antigen which
induced monocytes from normal or immune subjects to inhibit toxoplasma
multiplication did not influence parasite growth in HeLa cells . This finding
suggests that the active principal in the supernate is not interferon (43) . Kinetic
studies and the sensitivity of the supernate to heat suggest that the lymphocyte
product is notMIF (44) . Concentration and fractionation studies in progress are
directed towards the further characterization of this lymphocyte product .
Monocytes cultured with either lymphocytes from a tuberculin-positive
subject and PPD or supernates from Con A-stimulated lymphocytes did not
inhibit toxoplasma multiplication . These preliminary observations suggest a
specificity in the expression as well as in the induction of cellular immunity
against T. gondii and are in agreement with the findings of Hoffand Frenkel (45)
and Hirsch et al . (46) .
Summary
The multiplication of Toxoplasma gondii was quantitated in human monocytes
in vitro by phase-contrast microscopy . Toxoplasma multiplication was identical
in monocytes from subjects with established toxoplasma immunity and nonim-
mune subjects but was significantly inhibited in cells from both sources if the
monocytes were preincubated with immune lymphocytes and toxoplasma
antigen. Supernates prepared from toxoplasma-immune lymphocytes incubated
with toxoplasma antigen were also effective in inducing in monocytes the
capacity to inhibit toxoplasma multiplication . Supernate activity was evident
after lymphocytes and antigen were incubated for as little as 15 min. The
instruction of monocytes was also rapid and reversible . Monocytes were fully
induced to inhibit toxoplasma multiplication after a 2 h exposure to an active
supernate, but they lost their inhibitory capacity on culture in vitro for 48 h in
the absence of immune cells or their products . The lymphocytes participating in
the monocyte induction were identified as T cells . The in vitro stimulation of
monocytes appeared to exhibit some specificity, since no inhibition of toxo-
plasma multiplication occurred in monocytes incubated with either purified
protein derivative and lymphocytes from tuberculin-positive subjects, con-
canavalin A-stimulated lymphocytes, or their supernates . Supernates which
induced monocytes to inhibit toxoplasma multiplication did not influence
parasite growth in HeLa cells .
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